Stock data
Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. (WHWK) reported revenue of US$7.14M and net income of -US$20.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$7.14M | — | -US$114.40M | -US$20.60M | — |
| 2024 | US$25.98M | — | -US$67.46M | -US$63.69M | — |
| 2023 | US$24.35M | — | -US$71.93M | -US$65.77M | — |
| 2022 | US$15.22M | — | -US$62.68M | -US$60.51M | — |
| 2021 | US$14.00M | — | -US$111.22M | -US$110.09M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$16.64M | — |
| 2026-03-31 | US$0.00M | -US$22.19M | — |
| 2025-12-31 | US$0.00M | -US$23.25M | — |
| 2025-09-30 | US$0.00M | -US$17.75M | — |
| 2025-06-30 | US$0.00M | -US$52.62M | — |
| 2025-03-31 | US$7.14M | US$73.02M | — |
| 2024-12-31 | US$7.24M | -US$18.27M | — |
| 2024-09-30 | US$7.21M | -US$12.55M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.